Yat-Sun Or is the Senior Vice President and Chief Scientific Officer at Enanta Pharmaceuticals, where he has directed drug discovery since 1999. He is a prolific inventor with over 260 filed U. S. patent applications and holds a Ph. D. in Organic Chemistry from the University of Chicago.
He is the co-inventor of Enantas commercially successful protease inhibitors, glecaprevir (MAVYRET®) and paritaprevir (VIEKIRA PAK®), for the treatment of chronic hepatitis C virus.
Yat-Sun Or
SrVP and CSO at Enanta Pharmaceuticals
Watertown, Massachusetts, United States
Overview
Topics They Care About
Antiviral Drug Discovery
Leads scientific research for virology and immunology at Enanta and is a co-inventor on numerous patents for antiviral compounds targeting HCV, RSV, and other viruses.
Hepatitis C Therapeutics
Played a pivotal role in inventing glecaprevir and paritaprevir, two commercially successful drugs that have significantly impacted Hepatitis C (HCV) treatment.
Medicinal Chemistry
His Ph. D. is in Organic Chemistry, and his career is distinguished by discovering and developing small molecule drugs, receiving two Chairman's Awards at Abbott Labs for his research.
Media Appearances
Yat-Sun has no verified media appearances
Work History
SrVP and CSO at Enanta Pharmaceuticals
CSO at Enanta Pharmaceuticals
Education
Yat-Sun has no verified education history
More Information
Social Presence :
Prographics :
Exp : N/A
Location : Watertown, Massachusetts, United States
Job Level : N/A
Designation : SrVP and CSO at Enanta Pharmaceuticals
